DOSE MODIFICATION FOR CHINESE PATIENTS ON NIRAPARIB MAINTENANCE TREATMENT FOR PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: A POST HOC ANALYSIS

被引：0
|
作者：
Liu, Z. [1 ]
Wu, X. [2 ]
Zhu, J. [3 ]
Yin, R. [4 ,5 ]
Yang, J. [6 ]
Liu, J. [7 ]
Wang, J. [8 ]
Wu, L. [9 ]
Tan, T. [10 ]
Dong, J. [10 ]
机构：
[1] First Hosp Jilin Univ, Dept Oncol, Changchun, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, Dept Gynecol Oncol, Shanghai, Peoples R China
[3] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Dept Gynecol Oncol, Hangzhou, Peoples R China
[4] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu, Peoples R China
[5] Sichuan Univ, West China Univ Hosp 2, Key Lab Birth Defects & Related Dis Women & Child, Minist Educ, Chengdu, Peoples R China
[6] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gynecol Oncol, Beijing, Peoples R China
[7] Sun Yat Sen Univ, Canc Ctr, Dept Gynecol Oncol, Guangzhou, Peoples R China
[8] Cent South Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Xiangya Sch Med,Dept Gynecol Oncol, Changsha, Peoples R China
[9] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Dept Gynecol Oncol, Beijing, Peoples R China
[10] Zai Lab Shanghai Co Ltd, RandD Dept, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2021年 / 31卷
关键词：
D O I：
10.1136/ijgc-2021-ESGO.333
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
29
引用
收藏
页码：A193 / A194
页数：3
相关论文
共 50 条
  • [1] Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
    Mirza, M. R.
    Monk, B. J.
    Herrstedt, J.
    Oza, A. M.
    Mahner, S.
    Redondo, A.
    Fabbro, M.
    Ledermann, J. A.
    Lorusso, D.
    Vergote, I.
    Ben-Baruch, N. E.
    Marth, C.
    Madry, R.
    Christensen, R. D.
    Berek, J. S.
    Dorum, A.
    Tinker, A. V.
    du Bois, A.
    Gonzalez-Martin, A.
    Follana, P.
    Benigno, B.
    Rosenberg, P.
    Gilbert, L.
    Rimel, B. J.
    Buscema, J.
    Balser, J. P.
    Agarwal, S.
    Matulonis, U. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22): : 2154 - 2164
  • [2] Cost-effectiveness analysis of niraparib maintenance therapy in Chinese patients with platinum-sensitive recurrent ovarian cancer
    Qiu, Yijin
    Zha, Jingkai
    Ma, Aixia
    Zhou, Ting
    GYNECOLOGIC ONCOLOGY, 2023, 174 : 175 - 181
  • [3] EFFICACY AND SAFETY OF NIRAPARIB MAINTENANCE TREATMENT IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER AFTER SHORTER OR LONGER CHEMOTHERAPY: A POST HOC SUBGROUP ANALYSIS
    Gao, Y.
    Wu, X.
    Zhu, J.
    Yin, R.
    Yang, J.
    Liu, J.
    Wang, J.
    Wu, L.
    Liu, Z.
    Wang, D.
    Lou, G.
    Yang, H.
    Zhou, Q.
    Kong, B.
    Huang, Y.
    Chen, L.
    Li, G.
    An, R.
    Tan, T.
    Dong, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A10 - A11
  • [4] Real-Life Data of Niraparib Maintenance Treatment in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 10 - 11
  • [5] Budget impact analysis of niraparib and olaparib for maintenance treatment of platinum-sensitive, recurrent ovarian cancer in the US
    Wu, Lei
    Zhong, Lixian
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (02) : 187 - 195
  • [6] Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer EDITORIAL COMMENT
    不详
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2017, 72 (02) : 91 - 92
  • [7] Real-life data of niraparib maintenance treatment in patients with recurrent platinum-sensitive ovarian cancer.
    Vilming, Bente
    Fallas-Dahl, Jorgen
    Bentzen, Anne-Gry
    Ingebrigtsen, Vibeke Anett
    Nilsen, Elisabeth Berge
    Vistad, Ingvild
    Dorum, Anne
    Solheim, Olesya
    Bjorge, Line
    Aune, Guro
    Lindemann, Kristina
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Cost-Effectiveness of Niraparib and Olaparib as Maintenance Therapy for Patients with Platinum-Sensitive Recurrent Ovarian Cancer
    Zhong, Lixian
    Anh Thu Tran
    Tomasino, Taylor
    Nugent, Elizabeth
    Smith, Judith A.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (12): : 1219 - 1228
  • [9] Maintenance with Trabectedin in the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer
    Guerra Alia, Eva Maria
    Sempere Ortega, Cayetano
    Cortes Salgado, Alfonso
    Sanchez Martinez, Concepcion
    Galindo Alvarez, Julio
    Perez Miez, Belen
    CASE REPORTS IN ONCOLOGY, 2019, 12 (02): : 447 - 455
  • [10] Cost-effectiveness analysis of olaparib and niraparib as maintenance therapy for women with recurrent platinum-sensitive ovarian cancer
    Leung, John Hang
    Lang, Hui-Chu
    Wang, Shyh-Yau
    Lo, Hsueh Fang
    Chan, Agnes L. F.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (03) : 489 - 496
12345